Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel G. Haller, MD
Abramson Cancer Center at Penn Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
154 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Porto Alegre Hospital
Porto Alegre, Rio Grande do Sul, Brazil
- Instituto de Oncologia de Soracaba
Sorocaba, São Paulo, Brazil
- Hospital Joao Alves Fiho
Aracaiu-SE, Brazil
- Hospital Socor
Belo Horizonte-MG, Brazil
- Hospital Erastos Gaertner
Curitiba-PR, Brazil
- Instituto Nacional de Cancer
Rio de Janeiro, Brazil
- Oncologistas Associados
Rio de Janeiro, Brazil
- Hospital Do Cancer A C Comargo
São Paulo, Brazil
- Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada
- University of Alberta
Edmonton, Alberta, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Royal Victoria Hospital, Barrie
Barrie, Ontario, Canada
- Northeastern Ontario Regional Cancer Centre, Sudbury
Greater Sudbury, Ontario, Canada
- Cancer Care Ontario-London Regional Cancer Centre
London, Ontario, Canada
- Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada
- Mount Sinai Hospital - Toronto
Toronto, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Toronto Sunnybrook Regional Cancer Centre
Toronto, Ontario, Canada
- Hopital Charles Lemoyne
Greenfield Park, Quebec, Canada
- Cite de la Sante de Laval
Laval, Quebec, Canada
- L'Hotel Dieu de Levis
Lévis, Quebec, Canada
- Hopital Du Sacre-Coeur de Montreal
Montreal, Quebec, Canada
- Jewish General Hospital - Montreal
Montreal, Quebec, Canada
- Maisonneuve-Rosemont Hospital
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Quebec, Canada
- Centre Hospitalier de L'Universitaire de Quebec, Pavillon Chul
Sainte-Foy, Quebec, Canada
- L'Hopital Laval
Ste-Foy, Quebec, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- Zoom International Incoporated
Saint Jerome Quebec, Canada
- Charles University Hospital
Hradec Králové, Czechia
- Fakultni Nemocnice V Motole
Prague, Czechia
- Onkologicka Klinka A Onkologicka Lab
Prague, Czechia
- Centre of Clinical Oncology and Radiation Oncology
České Budějovice, Czechia
- Fovarosi Onkormanyzat Szent Margit Korhaz, Okologia
Budapest, Hungary
- Kozponti Honvedkorhaz I. Belgyogyaszat
Budapest, Hungary
- National Institute of Oncology
Budapest, Hungary
- Semmelweis University
Budapest, Hungary
- Szent Laszlo Korhaz
Budapest, Hungary
- Debreceni Egyetem Onkologiai Tanzek
Debrecen, Hungary
- Petz Aladar County Hospital
Gydr, Hungary
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2000
- Primary completion
- —
- Completion
- 31 Oct 2008
- Last update posted
- 19 Dec 2013
- Registered enrollment
- —
- Registry id
- NCT00012389
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.